# Tally Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tally-health

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.tallyhealth.com
- Total disclosed funding: $10M
- Latest round: Seed (Apr 6, 2023)
- Investors on record: 4

## About

Based in New York, US, and founded in 2021, Tally Health LLC operates as a biotechnology company. The company was founded by David Sinclair and Whitney Casey. In April 2023, Tally Health raised USD 10 million in seed funding led by Tally Health, G9 Ventures, L Catterton, and Second Sight Ventures. As of 2023, the company’s CEO is Melanie Goldey.

Tally Health offers a longevity platform, which is a biotech aging research platform that develops anti-aging biological products to treat diseases including cancer, dementia, and cardiovascular disease. The company also provides the TallyAge™ test, which is a biological age test that improves patients’ health spans by identifying their biological age. In addition, the company sells these test kits online through its e-commerce platform.

The company generates revenue by offering its services on a subscription-based pricing plan. The plans include a monthly subscription (USD 199/month), a 6-month subscription (USD 159/month), and a 12-month subscription (USD 129/month).

The company plans to use the funds raised in April 2023 to support product research and development as well as the advancement of its technology.

## Funding rounds

- Seed, Apr 6, 2023, $10M — L Catterton, Forerunner Ventures, G9 Ventures, Second Sight Ventures

## Investors

- L Catterton (https://capitalatlas.ai/funds/l-catterton) — Seed
- Forerunner Ventures (https://capitalatlas.ai/funds/forerunner-ventures) — Seed
- G9 Ventures (https://capitalatlas.ai/funds/g9-ventures) — Seed
- Second Sight Ventures (https://capitalatlas.ai/funds/second-sight-ventures) — Seed